{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:56:43Z","timestamp":1790632603692,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00284-026-05117-4","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:19:05Z","timestamp":1786731545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detection of Natural Killer and Natural Killer T Cells Responses among Patients with Chronic Hepatitis C Infections in Sana\u2019a City-Yemen"],"prefix":"10.1007","volume":"83","author":[{"given":"Ahmed M.","family":"Abdulkareem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basheer A.","family":"Al-Ofairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour Ali","family":"Al-Amrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan K.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed A.","family":"Al-Jahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadhah Hassan","family":"Edrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiburaj","family":"Sugathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansam Wadia","family":"Al-shameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"AL-Farga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"5117_CR1","doi-asserted-by":"publisher","unstructured":"Rehermann B (2009) Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence, Jul. 01, The American Society for Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI39133","DOI":"10.1172\/JCI39133"},{"key":"5117_CR2","doi-asserted-by":"crossref","unstructured":"Rosen HR (2011) clinical practice Chronic Hepatitis C Infection. N Engl J Med 364:2429\u20132438","DOI":"10.1056\/NEJMcp1006613"},{"key":"5117_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12090","author":"L Golden-Mason","year":"2013","unstructured":"Golden-Mason L, Rosen HR (2013) Natural killer cells: Multifaceted players with key roles in hepatitis C immunity. Sep. https:\/\/doi.org\/10.1111\/imr.12090","journal-title":"Sep"},{"issue":"1","key":"5117_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.14740\/gr1081w","volume":"12","author":"M Collister","year":"2019","unstructured":"Collister M, Ellison C, Li Q, Minuk GY, Rempel JD, Kung SK (2019) The Influence of Hepatitis C Viral Loads on Natural Killer Cell Function. Gastroenterol Res 12(1):8\u201315. https:\/\/doi.org\/10.14740\/gr1081w","journal-title":"Gastroenterol Res"},{"key":"5117_CR5","doi-asserted-by":"publisher","unstructured":"Heim MH, Thimme R (2014) Innate and adaptive immune responses in HCV infections. J Hepatol 61:14\u201325. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.035","DOI":"10.1016\/j.jhep.2014.06.035"},{"key":"5117_CR6","unstructured":"Warid Maya R, Hasan Mohammed A, ESTIMATION OF IL-18 IN PATIENTS INFECTED WITH HBV AND HCV: CASE CONTROL STUDY (2022) Biochem. Cell. Arch 22(1):0\u2013000 [Online]. Available: https:\/\/connectjournals.com\/03896.2022.22.000"},{"key":"5117_CR7","doi-asserted-by":"publisher","unstructured":"Durantel D, Zoulim F (2009) Innate response to hepatitis B virus infection: Observations challenging the concept of a stealth virus. https:\/\/doi.org\/10.1002\/hep.23361","DOI":"10.1002\/hep.23361"},{"key":"5117_CR8","doi-asserted-by":"publisher","unstructured":"Sun JC, Beilke JN, Lanier LL (Jan. 2009) Adaptive immune features of natural killer cells. Nature 457:557\u2013561. https:\/\/doi.org\/10.1038\/nature07665","DOI":"10.1038\/nature07665"},{"key":"5117_CR9","doi-asserted-by":"publisher","unstructured":"Tarr AW, Urbanowicz RA, Ball JK (Jan. 2012) The role of humoral innate immunity in Hepatitis C virus infection. Viruses 4(1):1\u201327. https:\/\/doi.org\/10.3390\/v4010001","DOI":"10.3390\/v4010001"},{"key":"5117_CR10","doi-asserted-by":"publisher","unstructured":"Molla S (2016) Review on Human Immune Response against Hepatitis B Virus (HBV) Infection. J Emerg Dis Virol 2(2). https:\/\/doi.org\/10.16966\/2473-1846.117","DOI":"10.16966\/2473-1846.117"},{"key":"5117_CR11","doi-asserted-by":"publisher","unstructured":"Sung PS, Shin EC (2021) Immunological mechanisms for hepatocellular carcinoma risk after direct-acting antiviral treatment of hepatitis C virus infection MDPI. 02. https:\/\/doi.org\/10.3390\/jcm10020221","DOI":"10.3390\/jcm10020221"},{"issue":"10","key":"5117_CR12","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1002\/eji.201041361","volume":"41","author":"F Bozzano","year":"2011","unstructured":"Bozzano F et al (2011) Activating NK cell receptor expression\/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. Eur J Immunol 41(10):2905\u20132914. https:\/\/doi.org\/10.1002\/eji.201041361","journal-title":"Eur J Immunol"},{"key":"5117_CR13","doi-asserted-by":"publisher","unstructured":"Ji H-F, Wang J, Yu L, Niu J-Q, Ayana DA, Jiang Y-F (2019) High frequencies of CD158b\u2009+\u2009NK cells are associated with persistent hepatitis C virus infections. Ann Hepatol 12(4):371\u2013379. https:\/\/doi.org\/10.1016\/s1665-2681(19)31337-7","DOI":"10.1016\/s1665-2681(19)31337-7"},{"key":"5117_CR14","doi-asserted-by":"publisher","unstructured":"Gokhale NS, Vazquez C, Horner SM Hepatitis C virus: Strategies to evade antiviral responses. Dec 01 2014 Future Med Ltd https:\/\/doi.org\/10.2217\/fvl.14.89","DOI":"10.2217\/fvl.14.89"},{"key":"5117_CR15","doi-asserted-by":"publisher","unstructured":"Shalaby MM, Eshra KA, Sharaby RM, Amer IF (Mar. 2017) Flow Cytometric Detection of Natural Killer Cells and Natural Killer T Cells Changes in the Blood of Patients with Chronic Hepatitis C Virus Infection in an Egyptian University Hospital. Int J Curr Microbiol Appl Sci 6(3):1518. https:\/\/doi.org\/10.20546\/ijcmas.2017.603.173","DOI":"10.20546\/ijcmas.2017.603.173"},{"issue":"4","key":"5117_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.5114\/ceji.2021.109846","volume":"46","author":"A Zientarska","year":"2021","unstructured":"Zientarska A et al (2021) Gender as a factor affecting NK cell activity in patients successfully treated for chronic hepatitis C with direct-acting antivirals. Cent Eur J Immunol 46(4):481\u2013491. https:\/\/doi.org\/10.5114\/ceji.2021.109846","journal-title":"Cent Eur J Immunol"},{"key":"5117_CR17","doi-asserted-by":"publisher","unstructured":"Highton AJ, Schuster IS, Degli-Esposti MA, Altfeld M The role of natural killer cells in liver inflammation, https:\/\/doi.org\/10.1007\/s00281-021-00877-6\/Published","DOI":"10.1007\/s00281-021-00877-6\/Published"},{"key":"5117_CR18","doi-asserted-by":"publisher","unstructured":"Gianchecchi E, Delfino DV, Fierabracci A (2021) Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases? Front Media S A 19. https:\/\/doi.org\/10.3389\/fimmu.2021.616853","DOI":"10.3389\/fimmu.2021.616853"},{"issue":"6","key":"5117_CR19","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.14218\/JCTH.2021.00427","volume":"10","author":"X Zhang","year":"2022","unstructured":"Zhang X et al (2022) Direct-acting Antiviral-induced Transient Recovery of NK Cells in Early-stage Treatment of Chronic Hepatitis C Patients. J Clin Transl Hepatol 10(6):1117\u20131124. https:\/\/doi.org\/10.14218\/JCTH.2021.00427","journal-title":"J Clin Transl Hepatol"},{"key":"5117_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/nri2707","author":"MT Abreu","year":"2010","unstructured":"Abreu MT (2010) Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Feb. https:\/\/doi.org\/10.1038\/nri2707","journal-title":"Feb"},{"key":"5117_CR21","doi-asserted-by":"publisher","unstructured":"Abo-Ali FH, Farres MN, Shehata IH (Apr. 2011) Study of natural killer and natural killer T cells in chronic hepatitis C infection. Egypt Liver J 1(1):47\u201350. https:\/\/doi.org\/10.1097\/01.elx.0000397029.18047.78","DOI":"10.1097\/01.elx.0000397029.18047.78"},{"issue":"7","key":"5117_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ni1087","volume":"5","author":"M Yoneyama","year":"2004","unstructured":"Yoneyama M et al (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5(7):730\u2013737. https:\/\/doi.org\/10.1038\/ni1087","journal-title":"Nat Immunol"},{"issue":"3","key":"5117_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/imm.12247","volume":"142","author":"V Kumar","year":"2014","unstructured":"Kumar V, Delovitch TL (2014) Different subsets of natural killer T cells may vary in their roles in health and disease. Immunology 142(3):321\u2013336. https:\/\/doi.org\/10.1111\/imm.12247","journal-title":"Immunology"},{"key":"5117_CR24","doi-asserted-by":"publisher","unstructured":"Szereday L, Meggyes M, Halasz M, Szekeres-Bartho J, Par A, Par G (May 2016) Immunological changes in different patient populations with chronic hepatitis C virus infection. World J Gastroenterol 22(20):4848\u20134859. https:\/\/doi.org\/10.3748\/wjg.v22.i20.4848","DOI":"10.3748\/wjg.v22.i20.4848"},{"key":"5117_CR25","doi-asserted-by":"publisher","unstructured":"Bandyopadhyay K, Marrero I, Kumar V NKT cell subsets as key participants in liver physiology and pathology. May 01 2016 Chinese Soc Immunology. https:\/\/doi.org\/10.1038\/cmi.2015.115","DOI":"10.1038\/cmi.2015.115"},{"key":"5117_CR26","doi-asserted-by":"publisher","unstructured":"Li H et al (Nov. 2018) Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection. Gut 67(11):2035\u20132044. https:\/\/doi.org\/10.1136\/gutjnl-2017-314098","DOI":"10.1136\/gutjnl-2017-314098"},{"key":"5117_CR27","doi-asserted-by":"crossref","unstructured":"Hofga\u00a8rtner WT, Hofga\u00a8rtner H, Kant JA, Weck KE (2000) Hepatitis C Virus Quantitation: Optimization of Strategies for Detecting Low-Level Viremia, [Online]. Available: https:\/\/journals.asm.org\/journal\/jcm","DOI":"10.1128\/JCM.38.2.888-891.2000"},{"key":"5117_CR28","doi-asserted-by":"crossref","unstructured":"Alter MJ, Fabiani FL (2007) Epidemiology of hepatitis C virus infection PREVALENCE AND INCIDENCE, World J Gastroenterol, vol. 13, no. 17, pp. 2436\u20132441, [Online]. Available: www.wjgnet.comhttp:\/\/www.wjgnet.com\/1007-9327\/13\/2436.asp","DOI":"10.3748\/wjg.v13.i17.2436"},{"key":"5117_CR29","unstructured":"Yacob Mohammed Prevalence of, Hepatitis B, Hepatitis C and HIV among Chronic liver disease patients in selected hospitals, Addis Ababa, Ethiopia. M.Sc. thesis. Addis Ababa University"},{"key":"5117_CR30","unstructured":"Kamunge EW (2013) Exploring Knowledge, Attitudes and Practices of Registered Nurses Regarding the Spread of Nosocomial Infections, [Online] Available. https:\/\/scholarship.shu.edu\/dissertations\/1865"},{"key":"5117_CR31","doi-asserted-by":"publisher","unstructured":"Kerkar N, Hartjes K (2025) Hepatitis C Virus\u2013Pediatric and Adult Perspectives in the Current Decade, Jan. 01, Multidisciplinary Digital Publishing Institute (MDPI). https:\/\/doi.org\/10.3390\/pathogens14010011","DOI":"10.3390\/pathogens14010011"},{"key":"5117_CR32","doi-asserted-by":"publisher","unstructured":"Chang ML, Cheng JS, Chen WT, Shen YJ, Kuo CJ, Chien RN (Dec. 2025) Mixed cryoglobulinemia decelerates hepatocellular carcinoma development in hepatitis C patients with SVR by downregulating regulatory B cells: a 12-year prospective cohort study. Oncoimmunology 14(1):2470128. https:\/\/doi.org\/10.1080\/2162402X.2025.2470128","DOI":"10.1080\/2162402X.2025.2470128"},{"issue":"8","key":"5117_CR33","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/JCM.02448-06","volume":"45","author":"JR Ticehurst","year":"2007","unstructured":"Ticehurst JR, Hamzeh FM, Thomas DL (2007) Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis. J Clin Microbiol 45(8):2426\u20132433. https:\/\/doi.org\/10.1128\/JCM.02448-06","journal-title":"J Clin Microbiol"},{"key":"5117_CR34","unstructured":"Bostan N et al (2016) Risk factors involved in spread of HCV in patients from sub urban Rawalpindi and their association with existing genotypes. Trop Biomed 33(4):652\u2013662"},{"key":"5117_CR35","doi-asserted-by":"publisher","unstructured":"Wanlapakorn N, Chansaenroj J, Vichaiwattana P, Klinfueng S, Poovorawan Y (2025) Seroprevalence of antibodies to hepatitis A, B and C viruses across all age groups in Chonburi Province, Thailand, 2022\u20132023. Hum Vaccin Immunother 21(1). https:\/\/doi.org\/10.1080\/21645515.2025.2480403","DOI":"10.1080\/21645515.2025.2480403"},{"issue":"5","key":"5117_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.aohep.2019.03.009","volume":"18","author":"TMSC Cordeiro","year":"2019","unstructured":"Cordeiro TMSC, Ferreira RP, Filho, D\u2019Oliveira J\u00fanior A (2019) Factors associated with occupational and non-occupational viral hepatitis infections in Brazil between 2007\u20132014. Ann Hepatol 18(5):751\u2013756. https:\/\/doi.org\/10.1016\/j.aohep.2019.03.009","journal-title":"Ann Hepatol"},{"key":"5117_CR37","unstructured":"Hayat S, Naeem M (2018) Hepatitis B and C prevalence and its associated risk factors among school going children in urban and rural areas of District Muzaffar Garh, Pakistan [Online] Available. https:\/\/www.researchgate.net\/publication\/387339085"},{"key":"5117_CR38","doi-asserted-by":"publisher","unstructured":"Liu T et al (Dec. 2025) An epidemiological study of hepatitis virus infection in psychiatric patients in East China. BMC Public Health 25(1). https:\/\/doi.org\/10.1186\/s12889-025-22081-z","DOI":"10.1186\/s12889-025-22081-z"},{"key":"5117_CR39","doi-asserted-by":"publisher","unstructured":"Okafor IM, Ugwu SO, Okoroiwu HU (Dec. 2020) Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison. BMC Gastroenterol 20(1). https:\/\/doi.org\/10.1186\/s12876-020-01504-8","DOI":"10.1186\/s12876-020-01504-8"},{"key":"5117_CR40","doi-asserted-by":"publisher","unstructured":"Dambadarjaa D Hepatitis B, C, and, Virus Infections D et al (2022) and AFP Tumor Marker Prevalence among the Elderly Population in Mongolia: A Nationwide Survey, Journal of Preventive Medicine and Public Health 55(3):263\u2013272. https:\/\/doi.org\/10.3961\/JPMPH.21.573","DOI":"10.3961\/JPMPH.21.573"},{"key":"5117_CR41","doi-asserted-by":"publisher","unstructured":"Mackesy-Amiti ME, Falk J, Latkin C, Kaufmann M, Williams L, Boodram B (2022) Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior. Harm Reduct J 19(1). https:\/\/doi.org\/10.1186\/s12954-022-00642-4","DOI":"10.1186\/s12954-022-00642-4"},{"key":"5117_CR42","doi-asserted-by":"publisher","unstructured":"Uwimbabazi JC et al (Dec. 2024) Diversity, geographical distribution and predictive factors of Hepatitis C virus genotypes and subtypes in Rwanda. Acta Trop 260. https:\/\/doi.org\/10.1016\/j.actatropica.2024.107433","DOI":"10.1016\/j.actatropica.2024.107433"},{"key":"5117_CR43","unstructured":"Dieterich DT, Spivak JL (2003) Hematologic Disorders Associated with Hepatitis C Virus Infection and Their Management CURRENT THERAPIES FOR HCV INFECTION Approved treatments for HCV include IFN-a2a and IFN-a2b monotherapy, pegylated IFN-a2a (PEG-IFN, [Online] Available. https:\/\/academic.oup.com\/cid\/article\/37\/4\/533\/331606"},{"key":"5117_CR44","doi-asserted-by":"publisher","unstructured":"Wrotkowska M, Stalke P, Smiatacz T, Zaucha JM (Dec. 2014) Hematological Complications in chronic Hepatitis C Virus Infection. Blood 124:2169\u20132169. https:\/\/doi.org\/10.1182\/blood.v124.21.2169.2169","DOI":"10.1182\/blood.v124.21.2169.2169"},{"key":"5117_CR45","doi-asserted-by":"publisher","unstructured":"Dahal S, Upadhyay S, Banjade R, Dhakal P, Khanal N, Bhatt VR (2017) Thrombocytopenia in patients with chronic hepatitis C virus infection. Mediterr J Hematol Infect Dis 9(1). https:\/\/doi.org\/10.4084\/mjhid.2017.019","DOI":"10.4084\/mjhid.2017.019"},{"key":"5117_CR46","doi-asserted-by":"crossref","unstructured":"Mih\u0103il\u0103 R-G (2017) A look at platelet count in chronic hepatitis c infection. EMJ Hepatol 5(1):97\u2013103","DOI":"10.33590\/emjhepatol\/10310346"},{"key":"5117_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/IJNRD.S44656","volume":"6","author":"C Saifan","year":"2013","unstructured":"Saifan C, El-Charabaty E, Kleiner M, El-Sayegh S (2013) Effect of hepatitis C virus infection on erythropoiesis in patients on hemodialysis. Int J Nephrol Renovasc Dis 6:121\u2013124. https:\/\/doi.org\/10.2147\/IJNRD.S44656","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"5117_CR48","unstructured":"Israa DR, Zainal G, Safa DR, And AA, Obead WK, BIOCHEMICAL PARAMETERS IN RELATION TO SERUM ALPHA FETOPROTEIN & LEPTIN LEVELS IN IRAQI PATIENTS WITH CHRONIC LIVER DISEASES"},{"key":"5117_CR49","doi-asserted-by":"publisher","unstructured":"Demi\u0307rcan F, Kilin\u00e7 F, G\u00d6ZEL N, \u015eENATE\u015e ERKALMAB (2014) \u015eENATE\u015e E Hepatit C Enfeksiyonunda Ortalama Trombosit Hacminin De\u011ferlendirilmesi, Viral Hepatit Dergisi 20(1):11\u201314. https:\/\/doi.org\/10.4274\/vhd.65365","DOI":"10.4274\/vhd.65365"},{"key":"5117_CR50","doi-asserted-by":"publisher","unstructured":"R. NAR and F. M\u0130LLETL\u0130 SEZG\u0130N, The Relationship Between the Serum RNA Titers of Hepatitis C Virus and Biochemical Parameters in Chronic Hepatitis C Patients. Viral Hepatit Dergisi, 22, 1, pp. 28\u201333, (2016) https:\/\/doi.org\/10.4274\/vhd.24008","DOI":"10.4274\/vhd.24008"},{"key":"5117_CR51","doi-asserted-by":"publisher","unstructured":"Kaczmarek DJ et al (Apr. 2017) Alterations of the NK cell pool in HIV\/HCV coinfection. PLoS ONE 12(4). https:\/\/doi.org\/10.1371\/journal.pone.0174465","DOI":"10.1371\/journal.pone.0174465"},{"key":"5117_CR52","doi-asserted-by":"publisher","unstructured":"Ali RK et al (2019) Natural Killer T cells in Egyptian Patients with HCV-associated Non-alcoholic Fatty Liver Disease. Suez Canal Univ Med J 22(1):95\u2013105. https:\/\/doi.org\/10.21608\/scumj.2019.65514","DOI":"10.21608\/scumj.2019.65514"},{"key":"5117_CR53","doi-asserted-by":"publisher","unstructured":"Sirin MC, Cicioglu Aridogan B, Sesli Cetin E, Sirin FB (2019) Evaluation of biochemical, hematological, RIBA and PCR assays in predicting viremia in anti-HCV positive patients, J Infect Dev Ctries 13(8):736\u2013743. https:\/\/doi.org\/10.3855\/jidc.11426","DOI":"10.3855\/jidc.11426"},{"key":"5117_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.exger.2017.10.024","volume":"105","author":"G Pawelec","year":"2018","unstructured":"Pawelec G (2018) Age and immunity: What is immunosenescence? Exp Gerontol 105:4\u20139","journal-title":"Exp Gerontol"},{"key":"5117_CR55","doi-asserted-by":"publisher","unstructured":"Rosen HR, Doherty DG, Madrigal-Estebas L, O\u2019Farrelly C, Golden-Mason L (2008) Pretransplantation CD56\u2009+\u2009innate lymphocyte populations associated with severity of hepatitis C virus recurrence, Liver Transplantation 14(1):31\u201340. https:\/\/doi.org\/10.1002\/lt.21265","DOI":"10.1002\/lt.21265"},{"key":"5117_CR56","doi-asserted-by":"publisher","unstructured":"Oliviero B et al (2009) Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections. Gastroenterology 137(3). https:\/\/doi.org\/10.1053\/j.gastro.2009.05.047","DOI":"10.1053\/j.gastro.2009.05.047"},{"key":"5117_CR57","doi-asserted-by":"crossref","unstructured":"Huang YHXY (2015) Analysis of the relationship between peripheral blood T lymphocyte subsets and HCV RNA levels in patients with chronic hepatitis C, Genetics and Molecular Research 14 (3):10057\u201310063","DOI":"10.4238\/2015.August.21.12"},{"issue":"8","key":"5117_CR58","doi-asserted-by":"publisher","first-page":"216","DOI":"10.15698\/cst2018.07.150","volume":"2","author":"B Strunz","year":"2018","unstructured":"Strunz B, Hengst J, Wedemeyer H, Bj\u00f6rkstr\u00f6m NK (2018) Irreversible impact of chronic hepatitis C virus infection on human natural killer cell diversity. Cell Stress 2(8):216\u2013218","journal-title":"Cell Stress"},{"key":"5117_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2058738420929587","volume":"34","author":"RG Romanelli","year":"2020","unstructured":"Romanelli RG et al (2020) Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study. Int J Immunopathol Pharmacol 34:1\u20137. https:\/\/doi.org\/10.1177\/2058738420929587","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"5117_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/jmv.21340","volume":"81","author":"MAS anna Zarife","year":"2009","unstructured":"anna Zarife MAS et al (2009) Increased frequency of CD56Bright NK-cells, CD3 -CD16\u2009+\u2009CD56- NK-cells and activated CD4\u2009+\u2009T-cells or B-cells in parallel with CD4\u2009+\u2009CDC25 High T-cells control potentially viremia in blood donors with HCV. J Med Virol 81(1):49\u201359. https:\/\/doi.org\/10.1002\/jmv.21340","journal-title":"J Med Virol"},{"key":"5117_CR61","doi-asserted-by":"publisher","unstructured":"Nafady A, Nafady-Hego H, Abdelwahab NM, Eltellawy RHN, Abu Faddan NH (Oct. 2018) Peripheral lymphocytes analyses in children with chronic hepatitis C virus infection. Eur J Clin Invest 48(10). https:\/\/doi.org\/10.1111\/eci.13004","DOI":"10.1111\/eci.13004"},{"key":"5117_CR62","doi-asserted-by":"publisher","unstructured":"Kim BR, Chun S, Cho D, Kim KH (Jan. 2019) Association of neutrophil-to-lymphocyte ratio and natural killer cell activity revealed by measurement of interferon-gamma levels in a healthy population. J Clin Lab Anal 33(1). https:\/\/doi.org\/10.1002\/jcla.22640","DOI":"10.1002\/jcla.22640"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05117-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-05117-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05117-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:02:54Z","timestamp":1790629374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-05117-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5117"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-05117-4","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Research Ethics Review Committee of the Biological Sciences, Faculty of Science, Sana\u2019a University, Yemen. Written informed consent was obtained from all participants. This case-control study was conducted in accordance with declaration of Helsinki guidelines for minimal risk research.","order":2,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"514"}}